8.00
price down icon0.87%   -0.07
after-market Dopo l'orario di chiusura: 8.00
loading

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

pulisher
09:56 AM

Is Amneal Pharmaceuticals Inc. a good long term investmentPowerful profit generation - PrintWeekIndia

09:56 AM
pulisher
09:51 AM

Amneal Pharmaceuticals prices $600 million in senior secured notes, increases term loan - Investing.com

09:51 AM
pulisher
05:50 AM

Amneal Pharmaceuticals Prices $600M Senior Notes Offering - TipRanks

05:50 AM
pulisher
02:10 AM

Why Investors Shouldn't Be Surprised By Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) Low P/S - simplywall.st

02:10 AM
pulisher
Jul 23, 2025

What drives Amneal Pharmaceuticals Inc. stock priceOutstanding trading profits - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Amneal Pharmaceuticals Inc. Stock Analysis and ForecastUnrivaled growth potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Amneal Pharmaceuticals Inc. stockSignificant capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Amneal Announces Proposed Refinancing of Existing Credit - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

Amneal reports 3% revenue growth in Q2, advances deleveraging By Investing.com - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Amneal seeks to borrow $1.8 billion in new term loans, offers notes - Investing.com UK

Jul 21, 2025
pulisher
Jul 21, 2025

Amneal (AMRX) targets $2.55B debt refinancing via loans & notes | AMRX SEC FilingForm 8-K - Stock Titan

Jul 21, 2025
pulisher
Jul 21, 2025

Amneal Pharmaceuticals Reports Preliminary Q2 2025 Financial Results Indicating Growth and Deleveraging Efforts - Quiver Quantitative

Jul 21, 2025
pulisher
Jul 21, 2025

Amneal Pharmaceuticals Unveils Massive $2.55 Billion Debt Restructuring PlanWhat's Changing - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

Knight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada - The Manila Times

Jul 18, 2025
pulisher
Jul 18, 2025

Thérapeutique Knight annonce le dépôt d’une nouvelle soumission réglementaire pour CREXONT® (carbidopa et lévodopa) au Canada en capsules à libération prolongée - GlobeNewswire Inc.

Jul 18, 2025
pulisher
Jul 16, 2025

Parkinson's Disease Pipeline 2025: MOA and ROA Insights, - openPR.com

Jul 16, 2025
pulisher
Jul 13, 2025

Amneal Pharmaceuticals (AMRX) Announces FDA Approval of Prednisolone Acetate Ophthalmic Suspension - MSN

Jul 13, 2025
pulisher
Jul 10, 2025

Amneal to Report Second Quarter 2025 Results on August 5, 2025 - GlobeNewswire

Jul 10, 2025
pulisher
Jul 09, 2025

Amneal Earnings: How to Join Q2 2025 Results Call on August 5 - Stock Titan

Jul 09, 2025
pulisher
Jul 04, 2025

Riot Platforms selling more Bitfarms (BITF) - The Globe and Mail

Jul 04, 2025
pulisher
Jul 02, 2025

Analysts Bullish as Amneal Pharmaceuticals, Inc. (AMRX) Director Sells Over 94K Shares - Yahoo Finance

Jul 02, 2025
pulisher
Jun 30, 2025

Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance

Jun 30, 2025
pulisher
Jun 27, 2025

Kashiv’s Xolair Biosimilar Nears US And EU Filings As Phase III Data Reports - insights.citeline.com

Jun 27, 2025
pulisher
Jun 26, 2025

5 Revealing Analyst Questions From Amneal’s Q1 Earnings Call - FinancialContent

Jun 26, 2025
pulisher
Jun 25, 2025

Amneal reports positive phase 3 results for XOLAIR biosimilar By Investing.com - Investing.com Nigeria

Jun 25, 2025
pulisher
Jun 24, 2025

Amneal Pharmaceuticals Breaks Above 200-Day Moving AverageBullish for AMRX - Nasdaq

Jun 24, 2025
pulisher
Jun 19, 2025

Investing in Amneal Pharmaceuticals (NASDAQ:AMRX) three years ago would have delivered you a 157% gain - simplywall.st

Jun 19, 2025
pulisher
Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmac - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Insider Sell: Gautam Patel Sells 94,906 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

Parkinson’s Disease Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | AbbVie, Mitsubishi Tanabe Pharma (NeuroDerm), Cerevance, Amneal Pharma, Pharma Two B, Jazz Pharma - Barchart.com

Jun 17, 2025
pulisher
Jun 17, 2025

Parkinson's Disease Market to Show Remarkable Growth Trends - openPR.com

Jun 17, 2025
pulisher
Jun 13, 2025

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - Yahoo Finance

Jun 13, 2025
pulisher
Jun 13, 2025

Epinephrine Autoinjector Market Size, Share, and Competitive - openPR.com

Jun 13, 2025
pulisher
Jun 13, 2025

FDA approves Amneal’s prednisolone acetate eye drops, launch set for Q3 - Investing.com India

Jun 13, 2025
pulisher
Jun 13, 2025

FDA approves Amneal's prednisolone acetate ophthalmic suspension - Eyes On Eyecare

Jun 13, 2025
pulisher
Jun 12, 2025

Insider Sell: Gautam Patel Sells 56,426 Shares of Amneal Pharmaceuticals Inc (AMRX) - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Amneal Pharmaceuticals receives U.S. FDA approval for prednisolone acetate - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension - MarketScreener

Jun 12, 2025
$70.93
price down icon 3.25%
$14.69
price down icon 2.20%
$9.35
price down icon 0.21%
drug_manufacturers_specialty_generic RDY
$14.71
price up icon 0.75%
$131.64
price down icon 1.51%
$306.41
price up icon 0.26%
Capitalizzazione:     |  Volume (24 ore):